Recently, we have developed an 18F-labelled isotopologue of rucaparib, [18F]rucaparib [18], which could serve as a PARP-targeting PET imaging tool and provide useful clinical information in PARP- or chemo- therapies for cancer. Here, PARP1 is linked to cancer.